Lakomek M, Winkler H, Pekrun A, Krüger N, Sander M, Huppke P, Schröter W
Universitäts-Kinderklinik, Göttingen, Deutschland.
Enzyme Protein. 1994;48(3):149-63.
The dependence of the erythrocyte pyruvate kinase (PK)-catalyzed reaction on the glycolytic intermediates glucose-6-phosphate (Gluc-6-P), 2,3-diphosphoglycerate (2,3-DPG) and the nucleotides ADP and ATP was studied in normal individuals and 14 patients with PK deficiency. The Gluc-6-P concentrations in the erythrocytes are markedly elevated (4- to 6-fold) in 9 patients with severe hemolytic anemia compared to those 5 exhibiting a mild clinical course (up to 2-fold increased). 2,3-DPG is elevated up to 2 times compared to the controls whereas the measured ADP and ATP only slightly deviate from the normal range. Control experiments showed that these elevations of Gluc-6-P and 2,3-DPG do not depend on the number of reticulocytes. In enzyme kinetic terms, Gluc-6-P shifts the Hill coefficient to smaller values, i.e. suppresses the positive cooperativity (sigmoidal reaction kinetics), found in normal and some of the mutant enzymes and shift the noncooperative enzymes of some patients to an enzyme exhibiting negative cooperativity. The negative cooperativity already present in the enzymes of some of the patients suffering from severe hemolytic anemia becomes more pronounced upon addition of Gluc-6-P. Apparently 2,3-DPG acts as an antagonist to Gluc-6-P in increasing the Hill coefficient, i.e. enhancing the positive cooperativity of the normal enzyme. It shifts the hyperbolic patients' enzymes to a sigmoidal reaction type and the enzymes of those patients with negative cooperativity to a hyperbolic type. ADP and ATP show a similar behavior as 2,3-DPG, but additionally inhibit the enzyme at higher concentrations. The influence of all four phosphates on the Michaelis constant varies depending on the type of cooperativity, in some cases increasing and in some cases decreasing K0.5 PEP. With 7 of the patients, all of them with severe clinical course, a genetic analysis of their R-type PK gene was performed and genetic defects have been identified in the coding sequence. The found changes in the amino acid sequence and their corresponding location in the tertiary structure of the PK subunit can satisfactorily explain the alterations of the regulatory properties of the mutant enzymes thus allowing to establish a good correlation between altered structural and functional properties of the deficient enzyme and the severeness of the course of the disease.
在正常个体和14例丙酮酸激酶(PK)缺乏症患者中,研究了红细胞丙酮酸激酶催化反应对糖酵解中间产物6 - 磷酸葡萄糖(Gluc - 6 - P)、2,3 - 二磷酸甘油酸(2,3 - DPG)以及核苷酸ADP和ATP的依赖性。与5例临床病程较轻(升高达2倍)的患者相比,9例严重溶血性贫血患者红细胞中的Gluc - 6 - P浓度显著升高(4至6倍)。与对照组相比,2,3 - DPG升高达2倍,而测得的ADP和ATP仅略偏离正常范围。对照实验表明,Gluc - 6 - P和2,3 - DPG的这些升高与网织红细胞数量无关。从酶动力学角度来看,Gluc - 6 - P使希尔系数变为较小值,即抑制了正常酶和一些突变酶中存在的正协同性(S形反应动力学),并使一些患者的非协同性酶转变为表现出负协同性的酶。在添加Gluc - 6 - P后,一些患有严重溶血性贫血患者的酶中已存在的负协同性变得更加明显。显然,2,3 - DPG在增加希尔系数方面充当Gluc - 6 - P的拮抗剂,即增强正常酶的正协同性。它将双曲线型患者的酶转变为S形反应类型,并将具有负协同性的患者的酶转变为双曲线型。ADP和ATP表现出与2,3 - DPG类似的行为,但在较高浓度下还会抑制该酶。所有四种磷酸盐对米氏常数的影响因协同性类型而异,在某些情况下会增加K0.5 PEP,在某些情况下会降低K0.5 PEP。对7例患者(均为临床病程严重者)进行了其R型PK基因的遗传分析,并在编码序列中鉴定出了基因缺陷。在PK亚基三级结构中发现的氨基酸序列变化及其相应位置能够令人满意地解释突变酶调节特性的改变,从而在缺陷酶结构和功能特性的改变与疾病病程的严重程度之间建立良好的相关性。